Prostate Cancer

Abstract

The prostate is a walnut‐sized gland located between the bladder and external urinary sphincter through which the urethra passes. The primary function of the prostate is to produce the fluid that accompanies the ejaculate; hence, it is important in reproduction. Adenocarcinoma of the prostate is the fourth most commonly diagnosed cancer in men worldwide.

Keywords: prostate cancer; prostate‐specific antigen; radical prostatectomy; radiation therapy; androgen ablation therapy

References

Albertsen PC, Fryback DG, Storer BE, Kolon TF and Fine J (1995) Long‐term survival among men with conservatively treated localized prostate cancer. Journal of the American Medical Association 274: 626–631.

Bagshaw MA, Cox RS and Hancock SL (1994) Control of prostate cancer with radiotherapy: long‐term results. Journal of Urology 152: 1781–1785.

Bolla M, Collette L, Blank L et al. (2002) Long‐term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 360: 103–106.

Carter BS, Bova GS, Beaty TH et al. (1993) Hereditary prostate cancer: epidemiologic and clinical features. Journal of Urology 150: 797–802.

Catalona WJ, Partin AW, Slawin KM et al. (1998) Use of the percentage of free prostate‐specific antigen to enhance differentiation of prostate cancer from benign prostatic disease. Journal of the American Medical Association 279: 1542–1547.

Eastham JA and Scardino PT (2000) Radical prostatetomy for clinical stage T1 and T2 prostate cancer. In: Vogelzang NJ, Scardino PT, Shipley WU and Coffey DS (eds) Comprehensive Textbook of Genitourinary Oncology, pp. 722–738. Philadelphia: Lippincott Williams and Wilkins.

Hanks GE, Hanlon AL, Schultheiss TB et al. (1997) Conformal external beam treatment of prostate cancer. Urology 50: 87–92.

Holmberg L, Bill‐Axelson A, Helgesen F et al. (2002) A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. New England Journal of Medicine 347: 781–789.

Hugosson J, Aus G, Bergdahl C and Bergdahl S (1995) Prostate cancer mortality in patients surviving more than 10 years after diagnosis. Journal of Urology 154: 2115–2117.

Lin X, Tascilar M, Lee WH et al. (2001) GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells. American Journal of Pathology 159: 1815–1826.

Messing EM, Manola J, Sarosdy M et al. (1999) Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node‐positive prostate cancer. New England Journal of Medicine 341: 1781–1788.

Narla G, Heath KE, Reeves HL et al. (2001) KLF6, a candidate tumour suppressor gene mutated in prostate cancer. Science 294: 2563–2566.

Oesterling JE, Cooner WH, Jacobsen SJ, Guess HA and Lieber MM (1993) Influence of patient age on the serum PSA concentration. Urology Clinics of North America 20: 671–680.

Ragde H, Elgamal AA, Snow PB et al. (1998) Ten‐year disease free survival after transperineal sonography‐guided iodine‐125 brachytherapy with or without 45‐gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma. Cancer 83: 989–1001.

Steineck G, Helgesen F, Adolfsson J et al. (2002) Quality of life after radical prostatectomy or watchful waiting. New England Journal of Medicine 347: 790–796.

Steinberg GS, Carter BS, Beaty TH, Childs B and Walsh PC (1990) Family history and the risk of prostate cancer. Prostate 17: 337–340.

Thompson IM, Goodman PJ, Tangen CM et al. (2003) The influence of finasteride on the development of prostate cancer. New England Journal of Medicine 349: 215–224.

Tulinius H, Egilsson V, Olafsdottir GH and Sigvaldason H (1992) Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer. British Medical Journal 305: 855–857.

Further Reading

Raghavan D, Scher HI, Leibel SA and Lange P (1997) Principles and Practice of Genitourinary Oncology. Philadelphia: Lippincott‐Raven.

Shi X‐B, Gumerlock PH, Evans CP and deVere White RW (1998) The molecular basis of prostate cancer. In: Kurzrock R and Talpaz M (eds) Molecular Biology in Cancer Medicine, 2nd edn, pp. 411–426. London: Martin Duntz.

Vogelzang NJ, Scardino PT, Shipley WU and Coffey DS (2000) Comprehensive Textbook of Genitourinary Oncology, 2nd edn. Philadelphia: Lippincott Williams and Wilkins.

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Evans, Christopher P, and Busby, J Erik(May 2005) Prostate Cancer. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1038/npg.els.0003856]